Andrew Szilagyi
Overview
Explore the profile of Andrew Szilagyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, et al.
Inflamm Bowel Dis
. 2017 Jun;
23(9):1605-1613.
PMID: 28590343
Background: Cytomegalovirus (CMV) is frequently detected in patients with ulcerative colitis (UC). The impact of CMV infection on the outcome of UC exacerbation remains unclear. The benefit of combining antiviral...
12.
Szilagyi A, Galiatsatos P, Xue X
Nutr J
. 2016 Jul;
15(1):67.
PMID: 27411934
Background: Relationships between inflammatory bowel disease and lactose containing foods remain controversial and poorly defined regarding symptoms, nutritional outcomes, and epidemiologic associations for lactose maldigestion. Methods: A literature review was...
13.
Heron V, Fortinsky K, Spiegle G, Hilzenrat N, Szilagyi A
Case Rep Gastroenterol
. 2016 Jul;
10(1):50-6.
PMID: 27403102
Hepatocellular carcinoma rarely occurs in patients without underlying cirrhosis or liver disease. While inflammatory bowel disease has been linked to certain forms of liver disease, hepatocellular carcinoma is exceedingly rare...
14.
Szilagyi A
Nutrients
. 2015 Aug;
7(8):6751-79.
PMID: 26287234
Dairy foods contain complex nutrients which interact with the host. Yet, evolution of lactase persistence has divided the human species into those that can or cannot digest lactose in adulthood....
15.
Szilagyi A
Can J Gastroenterol Hepatol
. 2015 Apr;
29(3):149-56.
PMID: 25855879
Background: Adult assimilation of lactose divides humans into dominant lactase-persistent and recessive nonpersistent phenotypes. Objectives: To review three medical parameters of lactose digestion, namely: the changing concept of lactose intolerance;...
16.
Galiatsatos P, Szilagyi A
Turk J Gastroenterol
. 2015 Jan;
25(2):227-8.
PMID: 25632421
No abstract available.
17.
Szilagyi A, Leighton H, Burstein B, Xue X
Clin Epidemiol
. 2014 Jun;
6:183-98.
PMID: 24971037
Countries with high lactase nonpersistence (LNP) or low lactase persistence (LP) populations have lower rates of some "western" diseases, mimicking the effects of sunshine and latitude. Inflammatory bowel disease (IBD),...
18.
Accuracy of biopsies for Helicobacter pylori in the presence of intestinal metaplasia of the stomach
Galiatsatos P, Wyse J, Szilagyi A
Turk J Gastroenterol
. 2014 Jun;
25(1):19-23.
PMID: 24918125
Background/aims: Gastric cancer is the second leading cause of cancer-related death worldwide. The majority of gastric cancers is "intestinal-type" adenocarcinoma, caused in part by H. pylori infection. Chronic gastritis leading...
19.
Szilagyi A, Galiatsatos P, Gologan A
Gastroenterol Hepatol (N Y)
. 2014 Apr;
9(11):757-8.
PMID: 24764798
No abstract available.
20.
Battat R, Kopylov U, Szilagyi A, Saxena A, Rosenblatt D, Warner M, et al.
Inflamm Bowel Dis
. 2014 Apr;
20(6):1120-8.
PMID: 24739632
Background: Management of vitamin B(12) (cobalamin, Cbl) deficiency in inflammatory bowel disease (IBD) is often not evidenced-based because of uncertainty on whether it causes enough malabsorption to result in clinical...